Decentralized clinical trials have emerged as a promising approach to overcome traditional barriers, enhance representation, and improve the quality of research by bringing biomedical studies directly into communities. However, recent policy changes under the Trump administration, including the removal of FDA guidance on clinical trial diversity, have raised concerns about the future of inclusive research.…